<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2794-1140</journal-id>
<journal-title><![CDATA[Pharmaceutical Care España]]></journal-title>
<abbrev-journal-title><![CDATA[Pharm Care Esp.]]></abbrev-journal-title>
<issn>2794-1140</issn>
<publisher>
<publisher-name><![CDATA[Fundación Pharmaceutical Care España]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2794-11402023000500005</article-id>
<article-id pub-id-type="doi">10.60103/phc.v25i5.821</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Propuesta de protocolo de dispensación activa de antineoplásicos orales para pacientes de novo en un servicio de farmacia hospitalaria]]></article-title>
<article-title xml:lang="en"><![CDATA[Proposal of an active dispensation protocol of oral antineoplasics for newly diagnosed patients for an outpatient hospital pharmacy service]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Arias-Núñez]]></surname>
<given-names><![CDATA[David]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Chavarría-Víquez]]></surname>
<given-names><![CDATA[Carolina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Quesada-Morúa]]></surname>
<given-names><![CDATA[María Soledad]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Costa Rica Facultad de Farmacia ]]></institution>
<addr-line><![CDATA[San Pedro de Montes de Oca ]]></addr-line>
<country>Costa Rica</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Caja Costarricense de Seguro Social Hospital México Servicio de Farmacia]]></institution>
<addr-line><![CDATA[San José ]]></addr-line>
<country>Costa Rica</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad de Costa Rica Facultad de Farmacia Departamento de Atención Farmacéutica y Farmacia Clínica]]></institution>
<addr-line><![CDATA[San Pedro de Montes de Oca ]]></addr-line>
<country>Costa Rica</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>10</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>10</month>
<year>2023</year>
</pub-date>
<volume>25</volume>
<numero>5</numero>
<fpage>5</fpage>
<lpage>19</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S2794-11402023000500005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S2794-11402023000500005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S2794-11402023000500005&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción: La propuesta para elaboración de un protocolo de dispensación activa de antineoplásicos orales para pacientes de novo responde a una necesidad detectada por el Servicio de Oncología y el Servicio de Farmacia de Consulta Externa y Urgencias del Hospital México. Actualmente los pacientes recién diagnosticados retiran los medicamentos sin la dispensación activa por el farmacéutico, lo cual puede comprometer la adherencia al tratamiento.  Objetivo: Proponer un protocolo de dispensación activa de antineoplásicos orales para pacientes de novo para la farmacia de consulta externa del Hospital México que le permita al personal farmacéutico brindar este servicio.  Método: Se realizó una búsqueda bibliográfica sobre los cánceres de próstata, pulmón y mama. Se seleccionaron los medicamentos a incluir en el programa. Se elaboró un protocolo de dispensación activa y los materiales educativos dirigidos a los pacientes atendidos por el Servicio de Farmacia de Consulta Externa y Urgencias del Hospital México con prescripción de antineoplásicos orales.  Resultados: Se incluyeron 11 antineoplásicos orales no contemplados en otros servicios de atención farmacéutica del Hospital México. Se desarrolló el procedimiento de dispensación activa según los lineamientos de la Caja Costarricense de Seguro Social para medicamentos de compra. Se elaboraron 11 boletines educativos para pacientes.  Conclusiones: El protocolo de dispensación activa de antineoplásicos orales propuesto permitirá que la farmacia de consulta externa del Hospital México brinde este servicio de forma estandarizada a los pacientes.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction: New patients prescribed with oral antineoplasics do not receive any indications on how to take their treatments properly. The outpatient pharmacy service of the Hospital México is in need for a protocol for active dispensing of oral antineoplasics to promote therapy adherence. Objective: The aim of this work was to propose an active dispensing protocol of oral antineoplasics for the outpatient pharmacy service of the Hospital México that enables pharmacists to offer this service to patients.  Method: A literature review was conducted on pulmonary, prostate and breast cancer, as well as on different pharmaceutical care programs to develop the active dispensing protocol and the information materials for patients.  Results: 11 oral antineoplasics were included in the program. A protocol for active dispensing of oral antineoplasics was developed, according to the guidelines of the Caja Costarricense de Seguro Social. Eleven patient information brochures were made.  Conclusion: The active dispensing program of oral antineoplasics developed will allow the outpatient pharmacy service of the Hospital México to offer a standardize service to patients.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[atención farmacéutica]]></kwd>
<kwd lng="es"><![CDATA[dispensación activa]]></kwd>
<kwd lng="es"><![CDATA[farmacia hospitalaria]]></kwd>
<kwd lng="es"><![CDATA[antineoplásicos orales]]></kwd>
<kwd lng="en"><![CDATA[pharmaceutical care]]></kwd>
<kwd lng="en"><![CDATA[active dispensing]]></kwd>
<kwd lng="en"><![CDATA[hospital pharmacy]]></kwd>
<kwd lng="en"><![CDATA[oral antineoplasics]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rueda de Lecea]]></surname>
<given-names><![CDATA[CV]]></given-names>
</name>
</person-group>
<source><![CDATA[Atención Farmacéutica en pacientes oncológicos]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Madrid España ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Complutense de Madrid]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<collab>Centro de Prensa</collab>
<source><![CDATA[Cáncer]]></source>
<year>2022</year>
<publisher-loc><![CDATA[Ginebra, Suiza ]]></publisher-loc>
<publisher-name><![CDATA[Organización Mundial de la Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<collab>International Agency for Research on Cancer</collab>
<source><![CDATA[Global Cancer Observatory]]></source>
<year>2020</year>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gater]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Heron]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Abetz-Webb]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Coombs]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Simmons]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Guilhot]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia]]></article-title>
<source><![CDATA[Leuk Res]]></source>
<year>2012</year>
<volume>36</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>817-25</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Englert]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Passero]]></surname>
<given-names><![CDATA[VA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dispensing and Monitoring Oral Anticancer Therapy]]></article-title>
<source><![CDATA[Fed Pract]]></source>
<year>2015</year>
<volume>32</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>38-41</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arias]]></surname>
<given-names><![CDATA[TD]]></given-names>
</name>
</person-group>
<source><![CDATA[Glosario de medicamentos: desarrollo, evaluación y uso]]></source>
<year>1999</year>
<edition>1</edition>
<publisher-loc><![CDATA[Washington ]]></publisher-loc>
<publisher-name><![CDATA[Organización Panamericana de la Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mislang]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Wildes]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Kanesvaran]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Baldini]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Holmes]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
<name>
<surname><![CDATA[Nightingale]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adherence to oral cancer therapy in older adults. The International Society of Geriatric Oncology (SIOG) taskforce recommendations]]></article-title>
<source><![CDATA[Cancer Treat Rev]]></source>
<year>2017</year>
<volume>57</volume>
<page-range>58-66</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ribed]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Romero-Jiménez]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Escudero-Vilaplana]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction]]></article-title>
<source><![CDATA[Int J Clin Pharm]]></source>
<year>2016</year>
<volume>38</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>280-8</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínes Flores]]></surname>
<given-names><![CDATA[IC]]></given-names>
</name>
</person-group>
<source><![CDATA[Implantación de la Consulta de Atención Farmacéutica A Pacientes Externos En la Unidad Nacional de Oncología Pediátrica]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Guatemala ]]></publisher-loc>
<publisher-name><![CDATA[Universidad de San Carlos de Guatemala]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Muluneh]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Schneider]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Faso]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Amerine]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Daniels]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Crisp]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy Management Program]]></article-title>
<source><![CDATA[J Oncol Pract]]></source>
<year>2018</year>
<volume>14</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>e324-34</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eyaralar]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Análisis de la dispensación en pacientes que inician tratamiento]]></article-title>
<source><![CDATA[Seguim Farmacoter]]></source>
<year>2004</year>
<volume>2</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>6-12</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Macaya]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Memoria Institucional]]></source>
<year>2021</year>
<publisher-name><![CDATA[Caja Costarricense de Seguro Social]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Avendaño Marchena]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Quesada Hernández]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Salvatierra Rojas]]></surname>
<given-names><![CDATA[MÁ]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez Barrantes]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
</person-group>
<source><![CDATA[Caja Costarricense de Seguro Social. Informe de auditoría]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[LG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Errores en el proceso de dispensación de medicamentos: Descripción de un caso con intervención]]></article-title>
<source><![CDATA[Fármacos]]></source>
<year>2005</year>
<volume>18</volume>
<numero>1-2</numero>
<issue>1-2</issue>
<page-range>6-14</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<collab>UptoDate</collab>
<article-title xml:lang=""><![CDATA[Drug information]]></article-title>
<source><![CDATA[UptoDate]]></source>
<year></year>
<publisher-name><![CDATA[Wolters Kluwer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bartel]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Safe practices and financial considerations in using oral chemotherapeutic agents]]></article-title>
<source><![CDATA[Am J Health-Syst Pharm]]></source>
<year>2007</year>
<volume>64</volume>
<numero>9 Suppl 5</numero>
<issue>9 Suppl 5</issue>
<page-range>S8-S14</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mancini]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Kaster]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Vu]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Modlin]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Wilson]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Implementation of a Pharmacist-Managed Interdisciplinary Oral Chemotherapy Program in a Community Cancer Center]]></article-title>
<source><![CDATA[J Hematol Oncol Pharm]]></source>
<year>2011</year>
<volume>1</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>23-30</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wong]]></surname>
<given-names><![CDATA[SF]]></given-names>
</name>
<name>
<surname><![CDATA[Bounthavong]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Nguyen]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bechtoldt]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Hernandez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Implementation, and preliminary outcomes of a comprehensive oral chemotherapy management clinic]]></article-title>
<source><![CDATA[Am J Health Syst Pharm]]></source>
<year>2014</year>
<volume>71</volume>
<page-range>960-5</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="">
<collab>Caja Costarricense de Seguro Social</collab>
<source><![CDATA[Lista Oficial de Medicamentos y Normativa]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="">
<collab>Dirección de Desarrollo de Servicios de Salud CC de SS</collab>
<source><![CDATA[Política Institucional de Atención Farmacéutica]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gurdián-Solórzano]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[León-Salas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cartín-Ruiz]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Santamaría-Ulloa]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Retiro de medicamentos antineoplásicos en un hospital nacional en Costa Rica]]></article-title>
<source><![CDATA[Rev OFIL-ILHAFAR]]></source>
<year>2020</year>
<volume>30</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>47-51</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dillmon]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Kennedy]]></surname>
<given-names><![CDATA[EB]]></given-names>
</name>
<name>
<surname><![CDATA[Reff]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patient-Centered Medically Integrated Dispensing: ASCO/NCODA Standards Summary]]></article-title>
<source><![CDATA[JCO Oncol Pract]]></source>
<year>2020</year>
<volume>16</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>344-8</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Neuss]]></surname>
<given-names><![CDATA[MN]]></given-names>
</name>
<name>
<surname><![CDATA[Polovich]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[McNiff]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Esper]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Gilmore]]></surname>
<given-names><![CDATA[TR]]></given-names>
</name>
<name>
<surname><![CDATA[LeFebvre]]></surname>
<given-names><![CDATA[KB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2013 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards Including Standards for the Safe Administration and Management of Oral Chemotherapy]]></article-title>
<source><![CDATA[JOP]]></source>
<year>2013</year>
<volume>9</volume>
<numero>2S</numero>
<issue>2S</issue>
<page-range>5s-13s</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Inglehart]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
<name>
<surname><![CDATA[Taberna]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pickard]]></surname>
<given-names><![CDATA[RKL]]></given-names>
</name>
<name>
<surname><![CDATA[Hoff]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Fakhry]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ozer]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[HPV knowledge gaps and information seeking by oral cancer patients]]></article-title>
<source><![CDATA[Oral Oncol]]></source>
<year>2016</year>
<volume>63</volume>
<page-range>23-9</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Codina]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Monografías Dr. Antonio Estevé. Educación Sanitaria: Información al paciente sobre los medicamentos]]></source>
<year>2000</year>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Doyma]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García-Izquierdo]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Muñoz-Miquel]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Los folletos de información oncológica en contextos hospitalarios: la perspectiva de pacientes y profesionales sanitarios]]></article-title>
<source><![CDATA[Panacea]]></source>
<year>2015</year>
<volume>16</volume>
<numero>42</numero>
<issue>42</issue>
<page-range>225-31</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santana]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Marcos]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Romero]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Administración de citostáticos vía oral: interacciones fármaco - alimento]]></article-title>
<source><![CDATA[Farm Hosp]]></source>
<year>2015</year>
<volume>39</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>203-9</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Citostáticos Orales: ¿Qué debemos saber?]]></article-title>
<source><![CDATA[Infac]]></source>
<year>2014</year>
<volume>22</volume>
<numero>8/9</numero>
<issue>8/9</issue>
<page-range>44-52</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aguilella Vizcaíno]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Atención farmacéutica hospitalaria en pacientes en tratamiento con antineoplásicos orales]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Madrid España ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Complutense de Madrid]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
